Page 9 - MELD Stimulant service
P. 9

5




            There are currently only inpatient medical interventions for the treatment of the
            conditions associated with conditions and syndromes associated with cocaine
            and amphetamine use. These may include the management of the physical
            signs of intoxication and withdrawal (e.g. unstable blood pressure, chest pain,
            seizures, stroke), treatment of stimulant-induced psychiatric disorders (e.g.
            severe anxiety, paranoia, mania, hallucinations), and treatment of a stimulant
            use disorder. However, these medical interventions are generally provided to
            in-patients in a medical setting.
            Treatments and interventions for stimulant use disorders are usually provided
            after the individual’s intoxication and withdrawal symptoms have resolved.
            Out-patient treatment options and programs for stimulant drug use rarely offer
            medical interventions; rather they offer psychosocial interventions of varying
            degrees of quality.

            The primary goals of these psychosocial interventions are to support the
            individual to reduce their use or remain abstinent from stimulant drugs.
            Promoting the service to these individuals and keeping them engaged in
            psychosocial interventions can be challenging.


            4.1  STIMULANT REFERRALS RECEIVED
                   BY MELD

            In the last three years, MELD have seen an increase in people presenting to
            service seeking support with reducing or stopping stimulant drug use. This has
            resulted in over 200 referrals to service. Referrals include cocaine, crack cocaine,
            amphetamines, meth amphetamines and NPS’s (new psychoactive substances).
            Although there was a decrease in 2021-2022, this number increased again
            in 2021-2023 with individuals reporting higher use with increased frequency
            during the last two years over the COVID-19 pandemic. Reasons for use include
            low mood, increased anxiety, fear, isolation and boredom. We also received
            feedback that it was far easier to access stimulant drugs during this time, in
            comparison to pre pandemic with dealers frequently in contact with individuals
            and delivering stimulant drugs straight to people’s doors.
   4   5   6   7   8   9   10   11   12   13   14